Evidence map›Paper›PMID 39660521›Full record

ReviewPharmaceutical nanotechnology2026

Silk Fibroin Hydrogels: Cutting-edge Developments and Future Directions.

Govindaraj Sabarees, Ganesan Padmini Tamilarasi, Jayaraman Rajangam, Veerachamy Alagarsamy, Viswas Raja Solomon

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pharmaceutical nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Govindaraj SabareesDepartment of Pharmaceutical Chemistry, Shri Venkateshwara College of Pharmacy, Ariyur, Puducherry 605102, India.
Ganesan Padmini TamilarasiDepartment of Pharmaceutical Chemistry, Shri Venkateshwara College of Pharmacy, Ariyur, Puducherry 605102, India.
Jayaraman RajangamDepartment of Pharmacology, Shri Venkateshwara College of Pharmacy, Ariyur, Puducherry, 605102, India.
Veerachamy AlagarsamyMedicinal Chemistry Research Laboratory, MNR College of Pharmacy, Greater Hyderabad, Sangareddy, 502294, India.
Viswas Raja SolomonMedicinal Chemistry Research Laboratory, MNR College of Pharmacy, Greater Hyderabad, Sangareddy, 502294, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The exploration of hydrogel materials has gained significant attention due to the ongoing period of collaborative interdisciplinary advancements. Silk fibroin (SF) possesses remarkable attributes, such as less immunogenicity, sterilization efficacy, processability without chemical crosslinkers, excellent biocompatibility, low immunogenicity, non-toxicity, mechanical strength, thermal stability, non-carcinogenicity, and adjustable biodegradability make it a highly valuable biomaterial. Silk fibroin hydrogel (SFH), a versatile biomaterial, has garnered significant attention due to its unique properties. Its biocompatibility, tunable mechanical properties, water retention capacity, and bioactive nature offer a unique combination of features that can effectively promote tissue regeneration and enhance wound healing. The utilization of SF for hydrogel production presents a valuable opportunity to leverage natural resources and promote eco-friendly production practices. With their exceptional properties and versatile applications in biomedicine, silk protein- based hydrogels hold promise for various research fields. This review aims to discuss the potential properties and recent advancements in the application of SF-based hydrogels for preclinical skin wound healing.

Indexed as

Biocompatible MaterialsFibroinsHydrogelsAnimalsHumansTissue EngineeringWound HealingBiocompatible MaterialsFibroinsHydrogelsbiomedicinehydrogelhydrogel fabricationSilk fibrointissue engineeringwound dressing

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.